Valuation: Merck KGaA

Capitalization 52.67B 61.68B 48.26B 45.63B 84.49B 5,903B 84.92B 575B 224B 2,801B 231B 227B 9,737B P/E ratio 2026 *
20.3x
P/E ratio 2027 * 17.5x
Enterprise value 60.31B 70.62B 55.26B 52.24B 96.73B 6,758B 97.23B 658B 256B 3,207B 265B 259B 11,148B EV / Sales 2026 *
2.89x
EV / Sales 2027 * 2.64x
Free-Float
29.73%
Yield 2026 *
1.93%
Yield 2027 * 2.01%
1 day+0.21%
1 week+5.53%
Current month+10.04%
1 month+3.90%
3 months-4.04%
6 months+3.02%
Current year-1.22%
1 week 110.95
Extreme 110.95
123.6
1 month 106.6
Extreme 106.6
123.6
Current year 100.7
Extreme 100.7
131.65
1 year 100.7
Extreme 100.7
131.65
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 60 01/05/2026
Director of Finance/CFO 55 01/07/2023
Chief Tech/Sci/R&D Officer - 01/07/2021
Director TitleAgeSince
Director/Board Member - 26/04/2019
Director/Board Member 63 01/05/2012
Director/Board Member 77 09/05/2014
Change 5d. change 1-year change 3-years change Capi.($)
+0.21%+5.53%-2.22%-26.54% 61.68B
-1.27%+5.55%+39.42%+112.34% 8.31B
+0.23%-1.27%+8.67%-12.64% 7.82B
-3.31%+0.71%+7.83%+37.97% 5.21B
-0.24%-3.53%-21.43%+56.30% 4.22B
-3.16%-3.25%+3.83%-21.43% 3.17B
+1.64%-0.17%+59.13%+50.48% 2.98B
+0.69%-2.25%+21.88%+12.66% 2.47B
-0.64%-3.63%+78.13%+37.73% 2.02B
+0.23%+13.61%+52.02%+17.45% 1.96B
Average -0.56%+0.49%+24.73%+26.43% 9.98B
Weighted average by Cap. -0.18%+4.13%+7.12%-1.43%

Financials

2026 *2027 *
Net sales 20.9B 24.47B 19.15B 18.1B 33.53B 2,342B 33.7B 228B 88.77B 1,112B 91.83B 89.91B 3,864B 21.95B 25.7B 20.11B 19.01B 35.2B 2,459B 35.38B 239B 93.21B 1,167B 96.42B 94.4B 4,057B
Net income 2.54B 2.98B 2.33B 2.2B 4.08B 285B 4.1B 27.73B 10.8B 135B 11.17B 10.93B 470B 2.99B 3.5B 2.74B 2.59B 4.8B 335B 4.82B 32.63B 12.7B 159B 13.14B 12.86B 553B
Net Debt 7.63B 8.94B 6.99B 6.61B 12.24B 856B 12.31B 83.29B 32.42B 406B 33.54B 32.84B 1,411B 5.28B 6.18B 4.83B 4.57B 8.46B 591B 8.51B 57.57B 22.41B 281B 23.18B 22.7B 975B
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
59,077
Date Price Change Volume
14/05/26 121.65 +0.41% 55,074
13/05/26 121.15 +7.21% 736,621
12/05/26 113.00 +0.09% 270,808
11/05/26 112.90 +0.04% 316,490
08/05/26 112.85 -1.66% 240,784
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
121.15EUR
Average target price
141.27EUR
Spread / Average Target
+16.60%

Quarterly revenue - Rate of surprise